Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis
Article in Neurology Neuroimmunology & Neuroinflammation (April 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
EBV infection drives MS pathology: Yes
Article in Multiple Sclerosis Journal (April 2024)
Understanding immune microenvironment alterations in the brain to improve the diagnosis and treatment of diverse brain diseases
Article in Cell Communication and Signaling (February 2024)